John Cijiang He Selected Research

SYTO 13

1/2022

Digital Spatial Profiling of Individual Glomeruli From Patients With Anti-Neutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Cijiang He Research Topics

Disease

21	Kidney Diseases (Kidney Disease) 01/2022 - 08/2004
21	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 07/2009
16	Fibrosis (Cirrhosis) 01/2022 - 03/2012
14	Proteinuria 01/2021 - 01/2011
11	Albuminuria 01/2021 - 01/2012
9	Chronic Renal Insufficiency 01/2022 - 07/2013
8	Inflammation (Inflammations) 01/2022 - 07/2013
6	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 01/2021 - 09/2004
6	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2020 - 09/2004
4	Glomerulonephritis 01/2022 - 08/2013
3	Hypertrophy 10/2021 - 01/2015
3	Disease Progression 10/2021 - 01/2014
3	HIV Infections (HIV Infection) 12/2018 - 03/2012
3	Lupus Nephritis 12/2018 - 05/2017
2	Ureteral Obstruction 01/2022 - 07/2013
2	COVID-19 01/2022 - 05/2020
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2022 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2012
2	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2020 - 07/2015
2	IGA Glomerulonephritis (IGA Nephropathy) 12/2018 - 01/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 08/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 07/2004
2	Infections 01/2007 - 09/2004
1	Colitis 01/2022
1	Cytokine Release Syndrome 01/2022
1	Rupture 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Vascular Calcification 01/2022
1	Dysbiosis 10/2021
1	Thoracic Aortic Aneurysm 01/2021
1	Aortic Dissection 01/2021
1	Marfan Syndrome (Marfan's Syndrome) 01/2021
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2021
1	Segmental glomerulosclerosis 01/2020
1	Vasculitis (Vasculitides) 01/2020

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
8	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
7	Sirtuin 1IBA 01/2022 - 01/2014
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2014
6	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 01/2007
5	CytokinesIBA 01/2022 - 07/2009
5	Protein Kinases (Protein Kinase)IBA 01/2021 - 03/2012
4	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2018
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 07/2009
4	Differentiation AntigensIBA 01/2021 - 11/2003
4	Streptozocin (Streptozotocin)FDA Link 01/2021 - 07/2009
4	nephrinIBA 11/2018 - 01/2012
4	Advanced Glycation End ProductsIBA 01/2017 - 07/2004
4	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2012
3	Messenger RNA (mRNA)IBA 01/2022 - 04/2016
3	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 10/2021 - 12/2017
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 05/2017
2	CollagenIBA 01/2022 - 07/2013
2	NF-kappa B (NF-kB)IBA 01/2022 - 08/2004
2	puerarinIBA 01/2022 - 11/2017
2	aristolochic acid I (aristolochic acid)IBA 01/2022 - 07/2017
2	RetinoidsIBA 01/2021 - 01/2014
2	CreatinineIBA 05/2020 - 01/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2016
2	AlbuminsIBA 01/2019 - 03/2016
2	SteroidsIBA 01/2018 - 01/2015
2	Uric Acid (Urate)IBA 01/2018 - 12/2017
2	Xanthine OxidaseIBA 01/2018 - 12/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015 - 03/2010
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2014 - 09/2004
2	Interleukin-10 (Interleukin 10)IBA 08/2013 - 07/2013
2	ChemokinesIBA 07/2013 - 08/2012
2	Oxidants (Oxidizing Agents)IBA 03/2010 - 08/2004
1	SYTO 13IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 01/2022
1	NAD (NADH)IBA 01/2022
1	ParaffinIBA 01/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	Sodium-Glucose Transport ProteinsIBA 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	Volatile Fatty AcidsIBA 10/2021
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2021
1	Phosphodiesterase 4 InhibitorsIBA 01/2021
1	AcidsIBA 01/2021
1	BI 2536IBA 01/2021
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 01/2021
1	PotassiumIBA 05/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2020
1	IronIBA 12/2019
1	arctigeninIBA 10/2019
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2019
1	Small Cytoplasmic RNAIBA 01/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2019

Therapy/Procedure

16	Therapeutics 01/2022 - 01/2011
3	Nephrectomy 10/2021 - 07/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2021